Aims Dual antiplatelet therapy reduces non-fatal ischaemic events after acute coronary syndrome (ACS) but increases bleeding to a similar extent. We sought to determine the prognostic impact of myocardial infarction (MI) vs. bleeding during an extended follow-up period to gain ...
4.1.2Acute coronary syndromes without persistent STEMIs (unstable angina and non-ST-segment myocardial infarction) Acute coronary syndromes (ACS) have a common pathophysiological substrate: atherosclerotic plaque rupture or surface erosion leads tothrombus formationand distal embolization and results in myoca...
Myocardial infarction (MI), colloquially known as “heart attack,” is caused by decreased or complete cessation of blood flow to a portion of the myocardium. Myocardial infarction may be “silent” and go undetected, or it could be a catastrophic event leading to hemodynamic deterioration and su...
Discrimination of patients with type 2 myocardial infarction. Eur Heart J. 2017;38(47):3514-3520. doi:10.1093/eurheartj/ehx457 PubMedGoogle ScholarCrossref 24. Chapman AR, Adamson PD, Shah ASV, et al; High-STEACS Investigators. High-sensitivity cardiac troponin and the ...
Treatment of major depression after acute coronary syndromes (ACS): Myocardial infarction or unstable angina: Sadhart trialdoi:10.1046/j.1443-9506.2000.07728.xElsevier B.V.Heart Lung & Circulation
NSTEACS: Non-ST elevation acute coronary syndromes NTproBNP: N-terminal pro-B type natriuretic peptide PaPPA: Pregnancy associated Plasma Protein A ROC AUC: Area under the receiver operating characteristic curve TIMI: Thrombolysis in Myocardial infarction study ...
Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet 367, 569–578 (2006). Galli, M. et al. Early anticoagulation in the current management of NSTE-ACS: evidence, ...
The most severe form of acute coronary syndrome (ACS) after sudden cardiac death is ST-segment elevation myocardial infarction (STEMI). According to the NRMI-4 (Fourth National Registry of Myocardial Infarction), 29% of infarction patients experience a STEMI (1), whereas a European survey, the...
TRIPLE THERAPY AFTER ACUTE MYOCARDIAL INFARCTION: A COMPARISON OF CLOPIDOGREL VERSUS PRASUGREL FROM THE TRANSLATE-ACS STUDYHemorrhagePalatine TonsilEditor's Summary Since the 1990s, the aim of open access (OA) has been to enhance scholarly communication by delivering scientific publications on the ...
Find all the latest on myocardial infarction at Medical Xpress. Your go-to source for news, research, and medical breakthroughs.